Products

Careverse CoronaryDoc (Careverse CoronaryDoc)
Careverse Technology Pte.
Cardiology AI
Careverse CoronaryDoc is an AI-powered coronary CTA analysis tool that automatically identifies coronary arteries, detects stenosis, and characterizes plaques, enhancing workflow efficiency and supporting early intervention in coronary artery disease.

See all 1 product →

About Careverse Technology Pte.

Careverse Technology is a global healthcare AI company dedicated to advancing smart healthcare through the integration of artificial intelligence with medical imaging. The company’s mission is to empower a new era of healthcare by developing an AI-powered “Digital Doctor” designed to enhance the efficiency, accuracy, consistency, and accessibility of patient care for physicians.

Their flagship “Digital Body” platform offers a comprehensive suite of over 40 AI-powered clinical applications, expanding to over 100 AI solutions as of March 2025. These solutions leverage various imaging modalities, including CT, MRI, Ultrasound, X-ray, and Mammography, to target critical therapeutic areas such as cardiovascular and cerebrovascular diseases, lung cancer, liver cancer, and breast cancer. The platform covers the heart, brain, abdomen, chest, and musculoskeletal system, aiming to optimize the entire disease management workflow from screening and diagnosis to treatment planning and follow-up.

Careverse Technology’s products, including “Digital Heart” (featuring CoronaryDoc and FFR), “Digital Brain,” “Digital Chest,” and “Digital Abdomen,” are designed to act as a “Healthcare Copilot” for radiologists and other medical professionals. The company has secured significant regulatory approvals, including FDA certification from the United States, MDR CE certification from the European Union, and numerous Chinese NMPA Class III certificates for its AI products, demonstrating their validated performance in clinical settings.

Focus Areas

AI-powered Digital Doctor medical imaging cardiovascular diseases cerebrovascular diseases lung cancer liver cancer breast cancer stroke imaging lung diseases liver imaging breast imaging thyroid imaging carotid artery imaging obstetrics imaging multimodal large language models AI+AR ultrasound systems

Business Intelligence

Key InvestorsGoldman Sachs Asset Management, Primavera Capital, Sequoia Capital China, General Atlantic, Vision Capital, Huagai Capital, Yuanyi Capital, Creation Ventures
PartnershipsDiagnostikum Group, Meinian Onehealth, Philips, GE, Wenzhou Health and Wellness Commission
TechnologyAI-powered Digital Doctor, Digital Body platform, multimodal medical large language model technology, AI+AR ultrasound system, AI Operating System for All Care
FDA Clearances2 cleared products (estimated)

What Physicians Need to Know

AI-powered Digital Doctor Platform
Careverse's 'Digital Doctor' platform is a comprehensive suite of over 40 AI-powered clinical applications designed to assist human doctors in delivering more efficient, accurate, consistent, and accessible patient care. It aims to empower a new era of smart healthcare.
Extensive Medical Imaging AI Solutions
The company offers over 100 AI solutions across multiple imaging modalities including CT, MRI, Ultrasound, X-ray, and Mammography. These solutions optimize the entire workflow from screening and diagnosis to treatment and follow-up, covering critical therapeutic areas like the heart, brain, abdomen, chest, and musculoskeletal system.
Cardiovascular Disease AI (Digital Heart)
The 'Digital Heart' suite includes products like Careverse CoronaryDoc, Careverse FFR, CacScoreDoc, and Plaque Analysis. It provides fully automated coronary CAD-RADs and CT-FFR analysis, offering diagnostic suggestions and pre-reports in as little as 3 minutes. It supports the diagnosis and treatment of cardiovascular diseases at various stages, including intelligent analysis of vulnerable plaques and cardiac function.
Cerebrovascular Disease & Stroke Imaging AI (Digital Brain)
The 'Digital Brain' suite offers AI solutions for the entire stroke imaging procedure, including Cerebral-CTA, CT Perfusion, Non-Contrast CT (ASPECTS Score, Hemorrhage), and Aneurysm detection. It streamlines post-processing, image interpretation, and report generation into a 3-minute workflow.
Lung Cancer & Lung Disease AI (Digital Chest)
Careverse's 'Digital Chest' solutions, such as LungDoc and PneumoniaDoc, provide early screening for multiple lung diseases and support 3D surgical planning. The platform offers auto image interpretation to derive disease information within 3 minutes and facilitates collaboration among radiologists, pulmonologists, and surgeons.
Liver Cancer & Liver Imaging AI (Digital Abdomen)
The 'Digital Abdomen' suite, featuring LiverMRDoc, provides AI-assisted diagnosis with LI-RADS standards for CT and MR liver imaging. It includes advanced 3D surgical planning, automatic MR sequence differentiation, and 3D reconstruction and segmentation for the entire liver and its vessels.
Breast Cancer & Breast Imaging AI (Digital Breast)
The 'Digital Breast' solutions, including MammographyDoc and BreastUsDoc Pro, empower the full patient journey from screening and diagnosis to treatment and follow-ups. This is further enhanced by their AI+AR ultrasound system.
Thyroid, Carotid Artery, and Obstetrics Imaging with AI+AR Ultrasound
Careverse has introduced the world's first AI+AR ultrasound system, covering breast, thyroid, carotid artery, and obstetric imaging. This innovative system analyzes ultrasound scans in real-time, overlaying AI-detected lesions directly onto the ultrasound screen with instant visualization and high precision.
Multimodal Large Language Models (MLLMs)
Careverse leverages MLLMs trained on petabytes of big data. These models integrate and compare different modalities of image data from the same patient, learn from medical literature and clinical guidelines, and output clinical reasoning analysis. They excel in text processing (report interpretation, real-time report generation, structured documentation) and image processing (auto-segmentation, detection, classification, cinematic rendering).
AI+AR Ultrasound Systems ('Turing Brain' and 'Turing AR')
Careverse integrates AI with ultrasound equipment through its 'Turing Brain' and 'Turing AR' hardware technologies. These systems enable real-time analysis of ultrasound video streams, displaying AI-enhanced lesion details directly on the original ultrasound screen to assist doctors during scanning and diagnosis.
Physician Tip

Careverse Technology Pte. stands out for physicians by acting as a 'Healthcare Copilot,' significantly enhancing efficiency, accuracy, and accessibility in patient care. Their comprehensive 'Digital Doctor' platform, with over 100 AI solutions across various imaging modalities, automates complex tasks and provides rapid, precise analysis (e.g., 3-minute workflows for cardiac and chest imaging). The integration of Multimodal Large Language Models offers advanced clinical reasoning, differential diagnosis assistance, and a holistic view of patient data by integrating diverse imaging and textual information. The pioneering AI+AR ultrasound systems provide real-time, on-screen visualization of lesions, directly assisting during scans. With numerous regulatory approvals (e.g., 12 MDR CE, 2 FDA 510(K)) and extensive clinical validation in thousands of hospitals globally, physicians can trust the reliability and performance of these tools, which are designed to seamlessly integrate into existing radiology workflows and offer localized deployment for data privacy. This allows physicians to reduce workload on routine tasks and focus more on complex cases and patient interaction.

Careverse's products are designed for seamless integration into existing radiology workflows and support various imaging modalities (CT, MRI, Ultrasound, X-ray, Mammography). They offer localized deployment within hospital intranets to ensure data privacy. The company actively collaborates with top research institutions and hospitals globally, indicating a commitment to interoperability and co-development within the healthcare ecosystem.

Products by Careverse Technology Pte.

1 product in the directory

Careverse CoronaryDoc (Careverse CoronaryDoc)
Careverse Technology Pte.
Cardiology AI
Careverse CoronaryDoc is an AI-powered coronary CTA analysis tool that automatically identifies coronary arteries, detects stenosis, and characterizes plaques, enhancing workflow efficiency and supporting early intervention in coronary artery disease.

What the Web Says

Careverse Technology Pte. appears to be a Singapore-based company, likely operating in the healthcare technology sector. Information regarding specific product reviews and employer opinions from major platforms like G2, Glassdoor, Capterra, or Reddit is scarce or non-existent in public web searches, suggesting it might be a newer or less publicly reviewed entity.

Overall: Mixed

Strengths

  • Unknown - insufficient public reviews available.
  • Potentially innovative in the healthcare tech space (inferred from company name and sector).
  • Likely based in Singapore, a hub for tech innovation.

Limitations

  • Lack of public reviews on major platforms (G2, Glassdoor, Capterra).
  • Limited visibility regarding product performance or employer satisfaction.
  • Difficulty in assessing company culture or product efficacy due to lack of data.
  • No readily available information from healthcare IT reviewers or Reddit discussions.

Based on reviews from: G2 (no specific reviews found), Glassdoor (no specific reviews found), Capterra (no specific reviews found), Healthcare IT reviewers (no specific reviews found), Reddit (no specific discussions found)

Last updated: 2026-07-17

Videos

News, demos, and interviews about Careverse Technology Pte..

Loading videos...

Videos load interactively. If none appear, search YouTube for Careverse Technology Pte. →

View all on YouTube

Press & Coverage

accessdata.fda.gov (FDA)
Careverse CoronaryDoc (Careverse CoronaryDoc) Substantially Equivalent - FDA 510(k) Premarket Notification K251656
Careverse Technology Pte. Ltd. received FDA 510(k) clearance for its Careverse CoronaryDoc, a medical image management and processing system, on September 4, 2025, determining it to be substantially equivalent to a predicate device.
2025-09
RadAI Slice
Careverse CoronaryDoc (Careverse CoronaryDoc) | FDA Radiology AI Device
Careverse CoronaryDoc, developed by Careverse Technology Pte. Ltd., is an automated software designed to process radiological images for more efficient and accurate analysis of coronary images, receiving FDA approval on September 4, 2025.
2025-09
Innolitics
2025 Year in Review: Cardiology AI/ML SaMD 510(k) Clearances
Careverse Technology Pte. Ltd.'s Careverse CoronaryDoc was among the 92 AI/ML-related FDA clearances in 2025, specifically noted in the cardiology AI/ML SaMD category for plaque-related tools.
2026-01
PR Newswire APAC
RSNA 2024 Spotlight: Careverse Leads the New Trend in Medical AI
Careverse Technology Pte. Ltd. highlighted its leadership in medical AI at RSNA 2024, showcasing its innovative solutions in the field.
2024-12
The Grid
CAREVERSE TECHNOLOGY PTE. LTD. - Profile, contacts and insights | The Grid
Careverse Technology is a global company focusing on 'artificial intelligence + healthcare,' with FDA certifications for two AI products (head and neck CTA and CTP) and MDR CE certification for four AI products as of October 2023.
2026-06
radiologyuae.com
ANNUAL RADIOLOGY MEETING IN DUBAI 2025 - EXHIBITION
Careverse Technology PTE Ltd. is listed as an exhibitor at the Annual Radiology Meeting in Dubai 2025, which focuses on cutting-edge technologies and applications in radiology, including artificial intelligence.
2025-10
acc.org
2026 ACC - Event Map
Careverse Technology PTE. LTD. is listed as an exhibitor at the 2026 American College of Cardiology (ACC) event.
2026-03
RecordOwl
CAREVERSE TECHNOLOGY PTE. LTD. (202239792R) - RecordOwl
CAREVERSE TECHNOLOGY PTE. LTD. was founded on November 9, 2022, and its principal activity is related to activities of head and regional head offices, with a secondary activity in research and experimental development on medical science.
2025-10

Frequently Asked Questions

Careverse offers a comprehensive suite of over 40 AI-powered clinical applications, including 'Digital Heart,' 'Digital Brain,' 'Digital Chest,' 'Digital Abdomen,' and 'Digital Breast,' for automated detection and analysis across various imaging modalities like CT, MRI, Ultrasound, X-ray, and Mammography. These solutions are designed for seamless integration with existing PACS, EMR/EHR systems, and hospital workflows to enhance diagnostic efficiency and accuracy.
Careverse has obtained 12 MDR CE markings, 2 FDA 510(K) approvals, and 1 PMDA Certificate for its AI solutions, demonstrating a commitment to clinical safety and efficacy. The company implements robust data encryption and access controls, adhering to global privacy standards like HIPAA and GDPR to safeguard patient information.
Careverse's AI solutions undergo rigorous clinical validation through extensive datasets and collaborations with medical institutions, demonstrating accuracy on par with expert human doctors. This validation ensures reliable support for physicians in diagnosing complex conditions such as stroke and early cancer, improving patient outcomes.
While specific pricing models are not publicly detailed, Careverse's solutions are designed to improve diagnostic efficiency, reduce physician workload, and enhance patient throughput. Healthcare organizations can expect significant return on investment through these operational improvements and the ability to deliver more efficient and accurate patient care.
Careverse emphasizes embedding its products into radiology workflows and collaborating with top research institutions, suggesting comprehensive support for integration and optimal performance. While explicit details on support tiers are not public, their widespread deployment in thousands of hospitals globally indicates robust implementation and ongoing assistance.
Careverse's long-term vision is to empower a new era of smart healthcare with an AI-powered Digital Doctor, continuously innovating with multimodal medical large language model technology and advancing AI+AR ultrasound systems. The company, founded in 2017, has completed a D round of funding led by Goldman Sachs Asset Management and Primavera Capital, indicating strong financial stability and a commitment to long-term innovation.
Careverse has introduced AI+AR ultrasound systems, including 'Turing Brain' and 'Turing AR' hardware technologies, which provide real-time augmented reality guidance and AI-powered analysis. These systems enhance visualization and measurement accuracy by overlaying AI-detected lesions directly onto the ultrasound screen, significantly improving detection and diagnostic processes for conditions in areas like breast, thyroid, carotid artery, and obstetrics.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.